Currently available models generally rely on cross-validation for quality assessment of model performance, although some models use literature-mining and small-scale forward genetics assays to characterize the quality of a few prioritized prediction results [51].
The iteration between model creation and qualitative model validation provides for quality assurance in the model creation process without the need of expensive – if not infeasible – parameterisation and quantitative simulation.
The results from the sequence analysis provide a further source of validation for the quality of our alternative and constitutive exon predictions.
Also, an initial validation of RA for quality management of social media data was presented [11].
The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-244X/11/203/prepub Apprecistion is expressed to Lilly colleagues Clarice Hayes for advising on factor analysis, April Naegeli for statistical code validation, and Khaled Sarsour for quality review.
We emphasise that content validation is crucial for quality enhancement and standardisation of openEHR information models, where a corresponding formal model must have its shortcomings to preserve the necessary flexibility.
This algorithm is based on a modified genomic Non-negative Matrix Factorization (gNMF) algorithm and includes several additional components, namely a pilot hierarchical clustering procedure to determine the number of clusters, a multiple random initiation scheme, a new stop criterion for the core gNMF, as well as a 10-fold cross-validation stability test for quality assessment.
However, typical in silico models are not suitable for regulatory purposes, as they have not taken into account one or more factors essential for validation, quality assurance, or for a specific application of a given compound.
This paper introduces exemplarily social epistemology as an underpinning theory for foresight validation by quality criteria.
Standard Reference Materials (SRMs) and Control Materials (CMs) intended for use in method development and validation as well as for quality assurance and for use in assigning values for selected environmental contaminants are also produced by NIST and provide a resource to ensure sample stability of specimens archived at the Marine ESB.
CDACs have been used extensively in the collection and validation of clinical data for quality improvement projects [ 3, 4].
